CStone Pharmaceuticals
HKEX:2616

Watchlist Manager

CStone Pharmaceuticals

HKEX:2616

Watchlist

Dividends

Discount Rate

Price: 1.81 HKD -0.55%

Market Cap: 2.3B HKD

Have any thoughts about
CStone Pharmaceuticals?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.81 HKD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

CStone Pharmaceuticals

1.81

-0.01 (-0.55%)

52 Week Range	0.82 2.7
Price Target

We'll email you a reminder when the closing price reaches HKD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

CStone Pharmaceuticals

What unique competitive advantages
does CStone Pharmaceuticals hold over its rivals?

What risks and challenges
does CStone Pharmaceuticals face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of CStone Pharmaceuticals.

What unique competitive advantages
does CStone Pharmaceuticals hold over its rivals?

What risks and challenges
does CStone Pharmaceuticals face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CStone Pharmaceuticals.

Provide P/S
for CStone Pharmaceuticals.

Provide P/E
for CStone Pharmaceuticals.

Provide P/OCF
for CStone Pharmaceuticals.

Provide P/FCFE
for CStone Pharmaceuticals.

Provide P/B
for CStone Pharmaceuticals.

Provide EV/S
for CStone Pharmaceuticals.

Provide EV/GP
for CStone Pharmaceuticals.

Provide EV/EBITDA
for CStone Pharmaceuticals.

Provide EV/EBIT
for CStone Pharmaceuticals.

Provide EV/OCF
for CStone Pharmaceuticals.

Provide EV/FCFF
for CStone Pharmaceuticals.

Provide EV/IC
for CStone Pharmaceuticals.

Show me price targets
for CStone Pharmaceuticals made by professional analysts.

What are the Revenue projections
for CStone Pharmaceuticals?

How accurate were the past Revenue estimates
for CStone Pharmaceuticals?

What are the Net Income projections
for CStone Pharmaceuticals?

How accurate were the past Net Income estimates
for CStone Pharmaceuticals?

What are the EPS projections
for CStone Pharmaceuticals?

How accurate were the past EPS estimates
for CStone Pharmaceuticals?

What are the EBIT projections
for CStone Pharmaceuticals?

How accurate were the past EBIT estimates
for CStone Pharmaceuticals?

Compare the revenue forecasts
for CStone Pharmaceuticals with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CStone Pharmaceuticals and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CStone Pharmaceuticals against its competitors.

Analyze the profit margins
(gross, operating, and net) of CStone Pharmaceuticals compared to its peers.

Compare the P/E ratios
of CStone Pharmaceuticals against its peers.

Discuss the investment returns and shareholder value creation
comparing CStone Pharmaceuticals with its peers.

Analyze the financial leverage
of CStone Pharmaceuticals compared to its main competitors.

Show all profitability ratios
for CStone Pharmaceuticals.

Provide ROE
for CStone Pharmaceuticals.

Provide ROA
for CStone Pharmaceuticals.

Provide ROIC
for CStone Pharmaceuticals.

Provide ROCE
for CStone Pharmaceuticals.

Provide Gross Margin
for CStone Pharmaceuticals.

Provide Operating Margin
for CStone Pharmaceuticals.

Provide Net Margin
for CStone Pharmaceuticals.

Provide FCF Margin
for CStone Pharmaceuticals.

Show all solvency ratios
for CStone Pharmaceuticals.

Provide D/E Ratio
for CStone Pharmaceuticals.

Provide D/A Ratio
for CStone Pharmaceuticals.

Provide Interest Coverage Ratio
for CStone Pharmaceuticals.

Provide Altman Z-Score Ratio
for CStone Pharmaceuticals.

Provide Quick Ratio
for CStone Pharmaceuticals.

Provide Current Ratio
for CStone Pharmaceuticals.

Provide Cash Ratio
for CStone Pharmaceuticals.

What is the historical Revenue growth
over the last 5 years for CStone Pharmaceuticals?

What is the historical Net Income growth
over the last 5 years for CStone Pharmaceuticals?

What is the current Free Cash Flow
of CStone Pharmaceuticals?

Discuss the annual earnings per share (EPS)
trend over the past five years for CStone Pharmaceuticals.

CStone Pharmaceuticals

Cash Flow Statement

Cash from Financing Activities

CStone Pharmaceuticals
Cash from Financing Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

CStone Pharmaceuticals
Cash from Financing Activities Peer Comparison

Comparables:

6160

603392

002252

300122

300896

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

	Cash from Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
CStone Pharmaceuticals HKEX:2616	Cash from Financing Activities ¥388.4m	CAGR 3-Years -35%	CAGR 5-Years -29%	CAGR 10-Years N/A
Beigene Ltd HKEX:6160	Cash from Financing Activities ¥2.6B	CAGR 3-Years -57%	CAGR 5-Years -25%	CAGR 10-Years N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Cash from Financing Activities -¥893.3m	CAGR 3-Years N/A	CAGR 5-Years -98%	CAGR 10-Years N/A
Shanghai RAAS Blood Products Co Ltd SZSE:002252	Cash from Financing Activities -¥1.2B	CAGR 3-Years -25%	CAGR 5-Years 5%	CAGR 10-Years N/A
Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Cash from Financing Activities -¥3.5B	CAGR 3-Years -1%	CAGR 5-Years -52%	CAGR 10-Years -47%
Imeik Technology Development Co Ltd SZSE:300896	Cash from Financing Activities -¥1.4B	CAGR 3-Years N/A	CAGR 5-Years -98%	CAGR 10-Years N/A

What is CStone Pharmaceuticals's Cash from Financing Activities?

Cash from Financing Activities
388.4m CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Cash from Financing Activities amounts to 388.4m CNY.

What is CStone Pharmaceuticals's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-29%

Over the last year, the Cash from Financing Activities growth was 25%. The average annual Cash from Financing Activities growth rates for CStone Pharmaceuticals have been -35% over the past three years , -29% over the past five years .

CStone Pharmaceuticals
HKEX:2616

CStone Pharmaceuticals
Cash from Financing Activities

CStone Pharmaceuticals
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is CStone Pharmaceuticals's Cash from Financing Activities?

Cash from Financing Activities
388.4m CNY

What is CStone Pharmaceuticals's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-29%

Company

Help

Tools

Stocks

CStone Pharmaceuticals HKEX:2616

CStone Pharmaceuticals Cash from Financing Activities

CStone Pharmaceuticals Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is CStone Pharmaceuticals's Cash from Financing Activities? Cash from Financing Activities 388.4m CNY

What is CStone Pharmaceuticals's Cash from Financing Activities growth rate? Cash from Financing Activities CAGR 5Y -29%

Company

Help

Tools

Stocks

CStone Pharmaceuticals
HKEX:2616

CStone Pharmaceuticals
Cash from Financing Activities

CStone Pharmaceuticals
Cash from Financing Activities Peer Comparison

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

What is CStone Pharmaceuticals's Cash from Financing Activities?

Cash from Financing Activities
388.4m CNY

What is CStone Pharmaceuticals's Cash from Financing Activities growth rate?

Cash from Financing Activities CAGR 5Y
-29%